All Akribion Therapeutics articles
-
NewsNew kind of CRISPR could treat viral infection and cancer by shredding sick cells’ DNA
A new technology uses a relative of the CRISPR-Cas9 gene editing system to kill target cells. When activated by a specific, programmable genetic target, the Cas12a2 protein rips a cell’s genome apart. Researchers programmed Cas12a2 to kill virus-infected cells or cancer cells while leaving healthy cells untouched.